AI-Powered Research Tools for the Life Sciences
Reliant AI saves biopharma professionals hours of time and effort, without sacrificing work quality.
Learn More
Play Video
Reliant AI saves biopharma professionals hours of time and effort, without sacrificing work quality.
Built By Alumni From
Let Reliant help you focus on what you do best with faster, safer, traceable AI.
“With the help of the Reliant deployment team, I significantly improved extraction quality for my SLRs... I don’t think Elicit, NotebookLM, etc., provide this level of targeted extraction from literature.”
Trusted By Teams At:
Our algorithm is more precise than the general-purpose AI tool your analyst is using.
In a recent study, our algorithm made 10x fewer errors than general-purpose AI tools.
Automate tedious work and improve output quality.
Free up time to focus on synthesis over screening.
Reliant Tabular accelerates rapid and systematic literature reviews.
Query easily with our AI-powered builder or import your abstracts from elsewhere.
Screen and extract data from full text PDFs and conference documents.
Support your findings by linking answers back to their source.
Pre-loaded with over 38 million documents from PubMed, ClinicalTrials.Gov, the latest conferences, and more.
Segment and filter drugs, trials, and publications.
Ask any question, and get structured conversational outputs.
Our experts, with backgrounds from Google DeepMind and leading private corporations and universities, understand your challenges because they've worked in your field
Marc G. Bellemare
Marc G. Bellemare, PhD, is the Co-founder of Reliant AI.
A Canada CIFAR AI Chair at Mila, his work on the Atari 2600 benchmark, published in Nature, is credited with launching the field of deep reinforcement learning (RL).
Marc has a history of applying cutting-edge RL commercially and previously led the RL team at Google Brain (Montréal) after his tenure as a research scientist at DeepMind (UK).
Richard Schlegel
Richard Schlegel, PhD, is a Co-founder and Head of Commercial at Reliant AI.
With a strong background in life sciences, he holds a PhD from Imperial College London where he researched lung cancer.
Richard’s commercial experience includes consulting roles at Navigant/Guidehouse, and most recently, with the EY-Parthenon Life Sciences Strategy team.
Karl Moritz Hermann
Karl Moritz, DPhil, is both CEO and Co-Founder of Reliant AI.
He divides his time between fundamental research in machine learning and applying AI to the real world. He holds a doctorate from Oxford in computational linguistics and machine learning.
Having sold his first startup, Dark Blue Labs, to Google in 2014, he worked as a senior staff researcher at DeepMind for five years.
Solutions to power life sciences literature analysis
Literature reviews have varying purposes, and so does our software. Reliant is built with results in mind, and our workflows support the diverse goals of biopharma professionals at all stages of their careers.
Solutions to power life sciences competitive landscaping
Reliant AI's competitive landscaping software is built to empower biopharma professionals with fast, accurate insights, no matter their role or goal.
Accelerate your systematic and targeted reviews with AI-augmented screening and extraction that gets you to insights faster without sacrificing precision.
Time Reclaimed
Unlock Massive Time Savings in Your Literature Review
Every hour spent manually excluding irrelevant abstracts is an hour taken away from synthesizing evidence. Reliant AI helps you tip the balance back toward high-value research tasks.
Savings calculated from a 3000-abstract benchmarking study comparing human screening with Reliant AI.
Extraction
Tabular does not restrict the volume of documents our users upload, so your research never faces a glass ceiling.
Screening
Quickly review abstracts, PDFs, and conference information and validate whether they fit your study's criteria.
Verification
Verify information in Reliant in seconds with quick notes, PDF highlighting, and easy project sharing.
Your secrets stay secrets
Our algorithm learns by reading open-access publications and databases, never on your data or intellectual property.
OMass Therapeutics
"With Reliant Tabular, we’ve been able to focus our time and energy on synthesizing high-quality outputs from data rather than menially sifting through it."
Hayden Consulting Group
I normally spend a lot of time preparing materials for primary market research, but Tabular saved me a whole week of work in a project.
Reliant AI is powered by brilliant minds who are actively shaping the future of biopharma and machine learning. We regularly publish new scientific research, white papers, and blogs across the life sciences and ML.
Unpack complex topics with detailed, expert-led guides.
Read our take on industry trends and challenges.
See our contributions to the scientific community in action
Make confident decisions in minutes, not weeks. Join thousands of researchers already transforming their work.